Author: Sequenom, Inc.
Source: Sequenom, Inc.
Interest: SAN DIEGO, Dec. 19, 2011 -- /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that numerous leading healthcare providers across the United States, including Women & Infants Hospital of Rhode Island, Vanderbilt University Medical Center, and Florida Hospital in Orlando have begun ordering the Sequenom Center for Molecular Medicine's (Sequenom CMM) MaterniT21 laboratory-developed test (LDT) for their patients. Th
Link: http://www.sacbee.com/2011/12/19/4132448/leading-us-healthcare-providers.html
Loading...